繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Exicure获得纳斯达克听证会小组的延期

2024-09-19 04:25

  • Exicure (NASDAQ:XCUR) said on Wednesday that Nasdaq Hearings Panel has granted an extension to continue the company’s listing subject to the company evidencing compliance with all applicable criteria by November 14, 2024.
  • The company has regained compliance with Nasdaq’s minimum bid price requirement and exchanged approximately $1M of indebtedness for equity at a conversion price of $3 per share.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。